Related references
Note: Only part of the references are listed.A novel method for detecting antigen-specific human regulatory T cells
Lisa M. Ebert et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2012)
Increased regulatory T-cell frequencies in patients with advanced melanoma correlate with a generally impaired T-cell responsiveness and are restored after dendritic cell-based vaccination
Anita Correll et al.
EXPERIMENTAL DERMATOLOGY (2010)
Human Tumor Antigen-Specific Helper and Regulatory T Cells Share Common Epitope Specificity but Exhibit Distinct T Cell Repertoire
Julien Fourcade et al.
JOURNAL OF IMMUNOLOGY (2010)
Monitoring of NY-ESO-1 specific CD4+ T cells using molecularly defined MHC class II/His-tag-peptide tetramers
Maha Ayyoub et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Selective expression of latency-associated peptide (LAP) and IL-1 receptor type I/II (CD121a/CD121b) on activated human FOXP3+ regulatory T cells allows for their purification from expansion cultures
Dat Q. Tran et al.
BLOOD (2009)
Tumor Antigen-Specific FOXP3+ CD4 T Cells Identified in Human Metastatic Melanoma: Peptide Vaccination Results in Selective Expansion of Th1-like Counterparts
Camilla Jandus et al.
CANCER RESEARCH (2009)
The CD4+ T-Cell Response of Melanoma Patients to a MAGE-A3 Peptide Vaccine Involves Potential Regulatory T Cells
Violaine Francois et al.
CANCER RESEARCH (2009)
Regulatory T-Cell - Mediated Attenuation of T-Cell Responses to the NY-ESO-1 ISCOMATRIX Vaccine in Patients with Advanced Malignant Melanoma
Theo Nicholaou et al.
CLINICAL CANCER RESEARCH (2009)
Vaccine trials in melanoma-time for reflection
Alexander M. M. Eggermont
NATURE REVIEWS CLINICAL ONCOLOGY (2009)
The Wilms' tumor antigen is a novel target for human CD4+ regulatory T cells:: Implications for immunotherapy
Cynthia Lehe et al.
CANCER RESEARCH (2008)
Regulatory T cells and immune tolerance
Shimon Sakaguchi et al.
CELL (2008)
Induction of tumor-specific CD4+ and CD8+ T-Cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine
Marij J. P. Welters et al.
CLINICAL CANCER RESEARCH (2008)
Circulating tumor antigen-specific regulatory T cells in patients with metastatic melanoma
Luis Vence et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Cutting edge:: Size and diversity of CD4+ CD25high Foxp3+ regulatory T cell repertoire in humans:: evidence for similarities and partial overlapping with CD4+ CD25-T cells
Nicolas Fazilleau et al.
JOURNAL OF IMMUNOLOGY (2007)
Association of cervical cancer with the presence of CD4+ regulatory T cells specific for human papillornavirus antigens
Sjoerd H. van der Burg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Metronomic cyclophosphamide regimen selectively depletes CD4+ CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients
Francois Ghiringhelli et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
A CFSE based assay for measuring CD4+CD25+ regulatory T cell mediated suppression of auto-antigen specific and polyclonal T cell responses
Koen Venken et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2007)
Transient regulatory T-cells: A state attained by all activated human T-cells
Vinodh Pillai et al.
CLINICAL IMMUNOLOGY (2007)
Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production
Sarah E. Allan et al.
INTERNATIONAL IMMUNOLOGY (2007)
Regulating the immune response to tumours
Gareth J. Betts et al.
ADVANCED DRUG DELIVERY REVIEWS (2006)
CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells
Weihong Liu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells
Nabila Seddiki et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development (vol 103, pg 6659, 2006)
MA Gavin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development
MA Gavin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Directions in the immune targeting of cancer: Lessons learned from the cancer-testis AgNY-ESO-1
Theo Nicholaou et al.
IMMUNOLOGY AND CELL BIOLOGY (2006)
Recognition of a new ARTC1 peptide ligand uniquely expressed in tumor cells by antigen-specific CD4+ regulatory T cells
HY Wang et al.
JOURNAL OF IMMUNOLOGY (2005)
Cord blood CD4+CD25+-derived T regulatory cell lines express FoxP3 protein and manifest potent suppressor function
WR Godfrey et al.
BLOOD (2005)
NY-ESO-1 protein formulated in ISCOMATRIX adjuvant is a potent anticancer vaccine inducing both humoral and CD8+ T-cell-mediated immunity and protection against NY-ESO-1+ tumors
E Maraskovsky et al.
CLINICAL CANCER RESEARCH (2004)
Cancer immunotherapy: moving beyond current vaccines
SA Rosenberg et al.
NATURE MEDICINE (2004)
A robust human T-cell culture method suitable for monitoring CD8+ and CD4+T-cell responses from cancer clinical trial samples
HM Jackson et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2004)
Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors
CS Hsieh et al.
IMMUNITY (2004)
Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humans
ID Davis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Immunodominant CD4+ responses identified in a patient vaccinated with full-length NY-ESO-1 formulated with ISCOMATRIX adjuvant
QY Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Tumor-specific human CD4(+) regulatory T cells and their ligands: Implications for immunotherapy
HY Wang et al.
IMMUNITY (2004)
Human CD25+ CD4+ T suppressor cell clones produce transforming growth factor β, but not interleukin 10, and are distinct from type 1 T regulatory cells
MK Levings et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
CD4+CD25high regulatory cells in human peripheral blood
C Baecher-Allan et al.
JOURNAL OF IMMUNOLOGY (2001)
CD4+ T cell recognition of MHC class II-restricted epitopes from NY-ESO-1 presented by a prevalent HLA DP4 allele:: Association with NY-ESO-1 antibody production
G Zeng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
On the dynamics of TCR:CD3 complex cell surface expression and downmodulation
HY Liu et al.
IMMUNITY (2000)
Identification of CD4+ T cell epitopes from NY-ESO-1 presented by HLA-DR molecules
G Zeng et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
